Alvimopan∗∗Alvimopan is the official USAN name adopted as of press time. (ADL 8-2698) Is a Novel Peripheral Opioid Antagonist (Q57480158)

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Insights into opioid action in the intestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Opioid antagonists in the treatment of opioid-induced constipation and pruritus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Opioid receptor expression in the rat gastrointestinal tract: a quantitative study with comparison to the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

The central and peripheral influences of opioids on gastrointestinal propulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

How does morphine work on colonic motility? An electromyographic study in the human left and sigmoid colon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Postoperative ileus: a preventable event

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Acute pain control and accelerated postoperative surgical recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Deflating postoperative ileus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Continuous epidural infusion of bupivacaine and morphine for postoperative analgesia after hysterectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Effects of perioperative analgesic technique on rate of recovery after colon surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

The effect of bupivacaine and morphine on pain and bowel function after colonic surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Effects of epidural bupivacaine and epidural morphine on bowel function and pain after hysterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Morphine effects on human colonic myoelectric activity in the postoperative period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Endogenous morphine is produced in response to cardiopulmonary bypass in neonatal pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Endogenous morphine--another component and biological modifier of the response to surgical injury?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Effect of surgical stress on endogenous morphine and cytokine levels in the plasma after laparoscopoic or open cholecystectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Review of postoperative ileus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Assessment of nalmefene glucuronide as a selective gut opioid antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Oral naloxone reverses opioid-associated constipation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X

Selective postoperative inhibition of gastrointestinal opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2801%2900784-X